[Opsoclonus-myoclonus syndrome associated with Mycoplasma pneumoniae infection]

Arch Pediatr. 2007 Aug;14(8):1003-6. doi: 10.1016/j.arcped.2007.04.010. Epub 2007 May 31.
[Article in French]

Abstract

Mycoplasma pneumoniae infection is associated with various manifestations involving the central nervous system but it has never been reported as a potential aetiology of opsoclonus-myoclonus syndrome (OMS) in children.

Observation: We report on a case in a 4-year-old girl who presented neurological manifestations compatible with an OMS, after a respiratory tract disease. Aetiological investigations revealed M. pneumoniae infection as specific IgM were present in the serum (Elisa). Evolution after corticosteroid, intravenous immunoglobulins and macrolide therapy was favourable as clinical symptoms disappeared. After a 12-month follow-up, the patient has no neurological sequela.

Conclusion: M. pneumoniae infection should be added to the list of causes to be screened in OMS. Its pathophysiology remains unknown but may involve a dysimmune postinfectious mechanism.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Child, Preschool
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Macrolides / therapeutic use
  • Methylprednisolone / therapeutic use
  • Mycoplasma pneumoniae / isolation & purification*
  • Opsoclonus-Myoclonus Syndrome / drug therapy
  • Opsoclonus-Myoclonus Syndrome / microbiology*
  • Pneumonia, Mycoplasma / complications*
  • Pneumonia, Mycoplasma / drug therapy

Substances

  • Adrenal Cortex Hormones
  • Immunoglobulins, Intravenous
  • Macrolides
  • Methylprednisolone